Pain Diagnostics, LLC

About Pain Diagnostics, LLC

In the United States, there are 66,000,000 people with chronic pain and headache. Johns Hopkins Hospital doctors have documented that 40%-80% of these people are misdiagnosed. Using AI, and Bayesian logic, the "expert system" questionnaires for headache and chronic pain generate diagnoses with a 96% correlation with those of Johns Hopkins Hospital doctors. The B2B version also makes testing recommendations based on Johns Hopkins Hospital protocols. For medical legal cases, the company has the Pain Validity Test, which can predict with 95% accuracy which patient will have abnormalities on medical testing, documenting organic pathology, and predict who will not have abnormalities with 94% accuracy, which can be used to detect fraud and drug seeking behavior. This test has always been admitted as evidence in 9 states. The B2C website is www.DiagnoseMyPains.com, and the B2B website is www.PainValidityTest.com. The CEO of the company is Ron Riewold, who has taken three companies public: 2 on NASDAQ and one on the NYSE, which was the largest pain treatment center company in the US, with $80 MM EBITDA. Recent sales contracts will begin Q2. Contact support@PainValidityTest.com for a free trial with the tests.